Neurology

Key articles from our newest issue

New potassium channel blocker used to improve walking in adults with multiple sclerosis and walking disability.

Preclinical research suggests vagus nerve could be key in the development of colitis

The Gairdner Foundation has announced the recipients of the 2012 Canadian Gairdner Awards, recognizing contributions to some of the most significant medical discoveries around the world.

New drug indicated for treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar I disorder.

Medtronic has received a licence from Health Canada for its deep brain stimulation (DBS) therapy for refractory epilepsy patients. This delivers controlled electrical pulses to a location inside the brain involved in seizures.